VITASPRING BIOMEDICAL CO. LTD.
VSBC · OTCMCIK 1697884fmd_0NG5A932XN3BPK9M2EDFM8TYVYServices · Services-Commercial Physical & Biological ResearchTemplate: Standard
Coverage: Feb 01, 2016 to Jul 31, 2026, 39 periods
| Line item | FY2020 | FY2020 | FY2020 | FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | – | – | – | – | 0 | 6 | 0 | 0 | 0 | 0 |
| Cost of revenue | – | – | 0 | – | 0 | 4 | 3 | 0 | 0 | 0 |
| Net investment income | – | – | – | – | 0 | (1) | – | – | – | – |
| Gross profit | – | – | 0 | – | 0 | 2 | (3) | 0 | 0 | 0 |
| Selling, general and administrative | – | – | 0 | – | – | 1 | 1 | 1 | 1 | 0 |
| Total operating expenses | – | – | – | – | – | – | – | – | – | – |
| Total benefits, losses and expenses | – | (0) | – | 0 | – | – | – | – | – | – |
| Operating income | 0 | – | – | – | 0 | 1 | (4) | (1) | (1) | (0) |
| Other non-operating income (expense) | – | – | 0 | – | 0 | 0 | (4) | 0 | – | – |
| Income before taxes | – | – | 0 | – | (0) | 1 | (4) | (1) | (1) | (0) |
| Income tax expense | – | – | 0 | – | 0 | 0 | (0) | 0 | 0 | 0 |
| Net income from continuing operations | – | – | 0 | – | (0) | 0 | (0) | (1) | (1) | (0) |
| Net income | 0 | – | – | – | 0 | 1 | (4) | (1) | (1) | (0) |
| Net income to common shareholders | – | – | – | – | – | – | – | – | – | – |